References in periodicals archive ?
Dusuk ALT seviyelerinin HBsAg kaybinda olumlu oldugunu ve aralikli dalgalanmalarin (ALT yuksekligi) izlendigi hastalarda NA'larin kesilmesini takiben kalici virolojik yanit olustugunu gosteren calismalar mevcuttur.
The HBsAg, anti-HBs, anti-HIV, and anti-HCV results were evaluated separately for each year (Table 2, Figure 1).
The study includes patients of all age groups & both sexes attending various outpatient departments or admitted in the wards of medicine, surgery, orthopedics, obstetrics and gynaecology or pediatrics, who were undergoing HBsAg test as part of routine preoperative screening or for diagnostic purposes.
HBsAg reductions were similar in hepatitis B e-antigen (HBeAg) positive and HBeAg negative patients.
Furthermore, HBsAg positivity represented a poor prognostic factor for complete response (CR) rate in Chinese patients with DLBCL.
Two programs (Chicago and Livingston/New York City) participated in HBV testing and vaccination of household contacts of persons who tested positive for HBsAg. These household contacts were offered HBV testing, and those whose test results were HBsAG-positive were linked to care; persons whose test results were HBsAG-negative with positive anti-HBs results (indicative of immunity through immunization or resolved infection) were reassured; and persons whose test results were negative for all three HBV seromarkers (susceptible to infection) were offered hepatitis B vaccination (3-dose series over 6 months).
The blood was allowed to clot and serum was separated by centrifugation at room temperature at 3000 rpm, and HBsAg was performed.
Spearman correlation coefficient was used to investigate the correlation among HBsAg, HBV DNA, and T lymphocytes.
Improvements in HBsAg assay sensitivity approaching the performance of nucleic acid testing (NAT) may impact the number of people who have treatment-induced undetectable HBsAg and are essential to further reduce the detection window for acute HBV infection in regions where NAT is not widely available.
* Infants weighing less than 2,000 g and born to mothers who are HBsAg negative: Administer the hepatitis B vaccine at hospital discharge or at age 1 month (whichever is first).
The sampling technique was purposive non probability and a total of 3776 samples of blood donors were tested for HBsAg and anti HCV antibodies in the year 2009 and 6740 blood donors were tested for HBsAg and anti HCV antibodies in the year 2014 using Architect System (Abbott).
Blood samples were tested against HBsAg and anti HCV by using ICT that were further confirmed by ELISA.
Acronyms browser ?
Full browser ?
- HBSC II